NEW DELHI – In a move that could further pave the way for Cipla Ltd., one of India's best-known makers of generics, to tap into the lucrative U.S. market, Invagen Pharmaceuticals Inc., a subsidiary of Mumbai-based Cipla, has entered a two-stage agreement to acquire the specialty hospital business of Avenue Therapeutics Inc. in the U.S.